相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SMYD2 is highly expressed in pediatric acute lymphoblastic leukemia and constitutes a bad prognostic factor
Luis Henrique Toshihiro Sakamoto et al.
LEUKEMIA RESEARCH (2014)
Context-specific regulation of cancer epigenomes by histone and transcription factor methylation
M. Sarris et al.
ONCOGENE (2014)
The Histone Methyltransferase SMYD2 Methylates PARP1 and Promotes Poly (ADP-ribosyl)ation Activity in Cancer Cells
Lianhua Piao et al.
NEOPLASIA (2014)
Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma
Y. Nishimura et al.
BRITISH JOURNAL OF CANCER (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
G9a, a multipotent regulator of gene expression
Shilpa Rani Shankar et al.
EPIGENETICS (2013)
A Medicinal Chemistry Perspective for Targeting Histone H3 Lysine-79 Methyltransferase DOT1 L
Justin L. Anglin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
The role of EZH2 in tumour progression
C-J Chang et al.
BRITISH JOURNAL OF CANCER (2012)
Overexpression of TRIM44 contributes to malignant outcome in gastric carcinoma
Kingo Kashimoto et al.
CANCER SCIENCE (2012)
Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor
Dominica Willmann et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Alterations of the TP53 Gene in Gastric and Esophageal Carcinogenesis
Marilanda Ferreira Bellini et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Control of Proinflammatory Gene Programs by Regulated Trimethylation and Demethylation of Histone H4K20
Joshua D. Stender et al.
MOLECULAR CELL (2012)
New lysine methyltransferase drug targets in cancer
Tobias Wagner et al.
NATURE BIOTECHNOLOGY (2012)
Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia
Tino Schenk et al.
NATURE MEDICINE (2012)
RB1 Methylation by SMYD2 Enhances Cell Cycle Progression through an Increase of RB1 Phosphorylation
Hyun-Soo Cho et al.
NEOPLASIA (2012)
Biochemical Characterization of Human SET and MYND Domain-Containing Protein 2 Methyltransferase
Jiaquan Wu et al.
BIOCHEMISTRY (2011)
Structural Basis of Substrate Methylation and Inhibition of SMYD2
Andrew D. Ferguson et al.
STRUCTURE (2011)
Proteomic analyses of the SMYD family interactomes identify HSP90 as a novel target for SMYD2
Mohamed Abu-Farha et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2011)
Gene trio signatures as molecular markers to predict response to doxorubicin cyclophosphamide neoadjuvant chemotherapy in breast cancer patients
M. C. Barros Filho et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2010)
Methylation of the Retinoblastoma Tumor Suppressor by SMYD2
Louis A. Saddic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Epigenetic modifications as therapeutic targets
Theresa K. Kelly et al.
NATURE BIOTECHNOLOGY (2010)
Identification of Smyd4 as a Potential Tumor Suppressor Gene Involved in Breast Cancer Development
Liping Hu et al.
CANCER RESEARCH (2009)
Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma
Shuhei Komatsu et al.
CARCINOGENESIS (2009)
Connexin26 expression is associated with aggressive phenotype in human papillary and follicular thyroid cancers
Yasuto Naoi et al.
CANCER LETTERS (2008)
Individualization of breast cancer based on histopathological features and molecular alterations
Hitoshi Tsuda
BREAST CANCER (2008)
The tale of two domains - Proteomics and genomics analysis of SMYD2, a new histone methyltransferase
Mohamed Abu-Farha et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
Repression of p53 activity by Smyd2-mediated methylation
Jing Huang et al.
NATURE (2006)
Identification and characterization of Smyd2: a split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex
Mark A. Brown et al.
MOLECULAR CANCER (2006)
Enhanced SMYD3 expression is essential for the growth of breast cancer cells
R Hamamoto et al.
CANCER SCIENCE (2006)
SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells
R Hamamoto et al.
NATURE CELL BIOLOGY (2004)
Regulation of p53 activity through lysine methylation
S Chuikov et al.
NATURE (2004)
Mutation and methylation of hMLH1 in gastric carcinomas with microsatellite instability
DC Fang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)
TP53 and gastric carcinoma: A review
CM Fenoglio-Preiser et al.
HUMAN MUTATION (2003)
Methylation and mutation analysis of p16 gene in gastric cancer
Y Ding et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)
Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas
N Oue et al.
JOURNAL OF PATHOLOGY (2002)
Extended local resection for advanced gastric cancer - Increased survival versus increased morbidity
RCG Martin et al.
ANNALS OF SURGERY (2002)
Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma
JH Lee et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Bop encodes a muscle-restricted protein containing MYND and SET domains and is essential for cardiac differentiation and morphogenesis
PD Gottlieb et al.
NATURE GENETICS (2002)
分享论文
